1. Leukemia. 2021 Feb;35(2):623-627. doi: 10.1038/s41375-020-0849-2. Epub 2020
May  5.

Genomic characterization of patients with polycythemia vera developing 
resistance to hydroxyurea.

Alvarez-Larrán A(1), Díaz-González A(2), Such E(2), Mora E(2), Andrade-Campos 
M(3), García-Hernández C(4), Gómez-Casares MT(5), García-Gutiérrez V(6), 
Carreño-Tarragona G(7), Garrote M(8), Fernández-Ibarrondo L(9), Cervera J(2), 
Bellosillo B(9), Cervantes F(8), Hernández-Boluda JC(10); MPN Spanish Group 
(GEMFIN).

Author information:
(1)Hematology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques 
August Pi i Sunyer (IDIBAPS), Barcelona, Spain. aalvar@clinic.cat.
(2)Hematology Department, Hospital La Fe, Valencia, Spain.
(3)Hematology Department, Hospital del Mar, IMIM, Barcelona, Spain.
(4)Hematology Department, Hospital General Universitario, Alicante, Spain.
(5)Hematology Department, Hospital Doctor Negrín, Las Palmas de gran Canaria, 
Spain.
(6)Hematology Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
(7)Hematology Department, Hospital 12 de Octubre, Madrid, Spain.
(8)Hematology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques 
August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
(9)Pathology Department, Hospital del Mar, IMIM, Barcelona, Spain.
(10)Hematology Department, Hospital Clínico, INCLIVA, Valencia, Spain.

DOI: 10.1038/s41375-020-0849-2
PMCID: PMC7862052
PMID: 32372025 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that they have no conflict 
of interest.